TARC Identifies Poor Dupilumab Response in Atopic Dermatitis ...Middle East

Serum thymus and activation-regulated chemokine (TARC) levels may pinpoint a category of atopic dermatitis cases needing the most intensive dupilumab treatment. Medscape Medical News

Hence then, the article about tarc identifies poor dupilumab response in atopic dermatitis was published today ( Thursday 22/04/2021 - 07:17 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TARC Identifies Poor Dupilumab Response in Atopic Dermatitis )

Also on site :

• World Cup 2026: Iran unlucky losers after missing out on last 32
• Iran-US war live: Trump warns Iran ‘will ​no longer exist’ as Tehran strikes US bases in Bahrain and Kuwait
• This CEO became 3x more productive with AI. Then she read what her daughter wrote about it at Dartmouth